awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33881653-62DB3297-5247-4304-B0C7-77502801DA7D
Q33881653-62DB3297-5247-4304-B0C7-77502801DA7D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33881653-62DB3297-5247-4304-B0C7-77502801DA7D
Formulary management of low molecular weight heparins.
P2860
Q33881653-62DB3297-5247-4304-B0C7-77502801DA7D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33881653-62DB3297-5247-4304-B0C7-77502801DA7D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ed1af239bdf21ea6ba09cd6d8a5af2b2488c2e85
P2860
Economic assessment of low-molecular-weight heparin (enoxaparin) versus unfractionated heparin in acute coronary syndrome patients: results from the ESSENCE randomized trial. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q wave Coronary Even